Go Back

Back to the main page

Combining AI and innovative hardware to deliver accurate 5-part differential CBC results in a compact analyzer

Small but powerful

OLO. Complete blood count from a fingerprick and two drops of blood

Compact, easy to use, and cost effective in low-volume settings, with 510(k) clearance for use in moderately complex labs.

OLO

Company growth trajectory

The story of OLO began in 2015, with the application of Sight’s digital fluorescent microscopy and advanced computer vision algorithms to revolutionize how Complete Blood Count (CBC) tests are done in the world. This innovation has since received FDA 510(k) clearance for use in moderate complexity laboratories in the United States.
Outside of the United States, OLO has the CE Mark according to the IVD European directive in point of care settings.

OLO, together with Parasight, OLO’s predecessor that diagnoses malaria based on the same breakthrough technology, extend Sight’s commercial footprint and impact across 5 continents.
Learn more about how you can help Sight take the next step toward transforming health systems and patient outcomes globally.





Icon

malaria kills
435,000 yearly

Icon


countries

Icon


600,000 kits sold

Icon
Icon
Laboratory

We’d love to
hear from you.

*please complete this field
*please complete this field
*please enter a valid email address
*please complete this field
*please complete this field
*please complete this field
*please complete this field
*please complete this field

Sorry, there was an error processing your request

Some fields are invalid. Please review the errors above and try again.

We got it!

We'll talk to you soon.